Objectives: To perform, in real conditions of prescription, the medico-economic evaluation of infliximab in severe RA.
Methods: A cost-effectiveness analysis of the annual costs was done with a comparison between the previous and the following year under infliximab. The effectiveness, determined from the HAQ, was expressed in clinically significant units and in quality-adjusted life years (QALYs).
Objective: We examined the longterm results of arthroscopic synovectomy in chronic knee synovitis of rheumatoid arthritis (RA).
Methods: Forty-one knees of 38 patients (30 women, 8 men), mean age of 42.7 +/- 15.